Stocks360

Rafael Holdings, Inc. (RFL)

Stock analysis · NYSE · Real Estate · Real Estate - Services

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
-1.77
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.35
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Rafael Holdings, Inc. (RFL) is a publicly traded company in the Real Estate sector. Trailing PE -1.77. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $1.34 2026-10-28 · $1.21 (-9.70%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Rafael Holdings, Inc.

Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-1.77×
P/S (TTM)63.23×
P/B0.82×
P/FCF (TTM)-1.94×
EV / EBITDA-1.03×
EV / Sales32.74×
Earnings Yield-52.52%
Free Cash Flow Yield-51.61%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$32.08M
Revenue (TTM)$980.00K
Net Income (TTM)-$32.54M
Free Cash Flow (TTM)-$31.49M
Net Debt-$29.89M
Working Capital$23.84M
Gross Margin84.39%
Operating Margin-3717.24%
Net Margin-3321.73%
Return on Equity-38.97%
Return on Invested Capital-44.50%

Peers

Recent News

Related

Browse more tickers: sitemap